| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1423-0410.2002.TB05347.X |
| P698 | PubMed publication ID | 12617181 |
| P2093 | author name string | Bernard Horowitz | |
| P304 | page(s) | 429-436 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Vox Sanguinis | Q15708866 |
| P1476 | title | Pathogen inactivated transfusion plasma: existing and emerging methods | |
| P478 | volume | 83 Suppl 1 |
| Q37776318 | A comparison of methods of pathogen inactivation of FFP |
| Q37119689 | A study of the quantity of some stable and labile coagulation factors in fresh-frozen plasma produced from whole blood stored for 24 hours in Iran |
| Q50787426 | Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C. |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q37062415 | Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma |
| Q39230229 | Therapeutic plasmas available worldwide |
| Q83808031 | [Techniques of preparation and indications of labile blood products] |
| Q85015878 | [Therapeutic plasmas] |
Search more.